10 November 2015 Oryzon Genomics Announces First Patient Dosed in Phase I Extension Cohort of ORY-1001
4 November 2015 ORYZON Announces the Appointment of Mr. Antonio Fornieles, Ms. Isabel Aguilera and Mr. Ramon Adell as Independent Directors
24 August 2015 ORYZON to Present at the 15ª Annual Biotech in Europe Forum for Global Partnering & Investment in Basel, Switzerland
27 August 2015 ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York, USA